Open Menu

Genomic and Molecular Characterisation of Respiratory Syncytial Virus in the National SARI Surveillance System Across Three Consecutive Seasons in North Macedonia (2022-2025)

Authors

Teodora Karevska

Institute for Public Health of the Republic of North Macedonia, Skopje

Golubinka Boshevska

Institute for Public Health of the Republic of North Macedonia, Skopje , Faculty of Medical Sciences, Goce Delchev University, Shtip

Elizabeta Jancheska

Institute for Public Health of the Republic of North Macedonia, Skopje

Maja Vukovikj

Institute for Public Health of the Republic of North Macedonia, Skopje

Senada Karishik

Institute for Public Health of the Republic of North Macedonia, Skopje

Gala Matevska

Institute for Public Health of the Republic of North Macedonia, Skopje

Gordana Nikolovska

Institute for Public Health of the Republic of North Macedonia, Skopje

Aneta Peshnachka

Institute for Public Health of the Republic of North Macedonia, Skopje

Dragan Kochinski

Institute for Public Health of the Republic of North Macedonia, Skopje

Kristina Stavridis

Institute for Public Health of the Republic of North Macedonia, Skopje

Enkela Polozhani

Institute for Public Health of the Republic of North Macedonia, Skopje

Milica Simova

Institute for Public Health of the Republic of North Macedonia, Skopje

Marija Andonovska

Institute for Public Health of the Republic of North Macedonia, Skopje

Gorica Popova

Faculty of Medical Sciences, Goce Delchev University, Shtip , PHI University Clinic for Respiratory Diseases in Children “Kozle”, Skopje

Icko Gjorgoski

Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss.Cyril and Methodius University, Skopje

DOI:

https://doi.org/10.5644/ama2006-124.508

Keywords:

Respiratory Syncytial Virus, SARI, Genomic Surveillance, Whole-Genome Sequencing, Molecular Epidemiology

Abstract

Objective . To describe the epidemiological, molecular, and genomic characteristics of respiratory syncytial virus (RSV) detected through the national severe acute respiratory infection (SARI) surveillance system in North Macedonia across three consecutive seasons (2022/2023-2024/2025).

Materials and Methods . This study analysed SARI surveillance data from seven hospital-based sentinel sites. RSV detection and subgroup determination were performed using reverse transcription quantitative polymerase chain reaction (RT-qPCR), following season-specific testing strategies, which should be considered when interpreting seasonal differences in RSV positivity. Consensus genomes were generated, and phylogenetic analyses were performed using contemporaneous European reference sequences. Amino acid substitutions in the G and F proteins were assessed descriptively.

Results . Among 1,899 laboratory-tested SARI cases, 53.3% were tested for RSV, of which 24.8% were positive. RSV-A predominated overall, although seasonal shifts in subgroup dominance were observed. RSV infections were concentrated among young children, particularly those aged 0-2 years. Whole-genome sequencing of 85 RSV-positive samples revealed a dynamic seasonal turnover of RSV-A lineages, whereas RSV-B circulation remained largely confined to a single dominant lineage across seasons. Analysis of antigenically important genes showed greater variability in the G gene compared with the more conserved F gene in both subgroups.

Conclusion . The integration of epidemiological, molecular, and whole-genome data within routine SARI surveillance provides a comprehensive overview of RSV circulation and evolution in North Macedonia. These findings contribute genomic data from an under-represented region and provide a foundation for future evaluation of RSV vaccination and mono- clonal antibody effectiveness by detecting viral genetic changes, should such measures be implemented in North Macedonia.

References

Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. The Lancet. 2022 May;399(10340):2047–64. doi:10.1016/S0140-6736(22)00478-0

Al-Leimon O, Shihadeh H, Yousef AA, Khraim A, Siwwad R. Respiratory syncytial virus: A review of current basic and clinical knowledge. Qatar Med J. 2024;2024(4):56. doi:10.5339/qmj.2024.56

Peret TCT, Hall CB, Hammond GW, Piedra PA, Storch GA, Sullender WM, et al. Circulation Patterns of Group A and B Human Respiratory Syncytial Virus Genotypes in 5 Communities in North America. J INFECT DIS. 2000 Jun;181(6):1891–6. doi:10.1086/315508

Cantú-Flores K, Rivera-Alfaro G, Muñoz-Escalante JC, Noyola DE. Global distribution of respiratory syncytial virus A and B infections: a systematic review. Pathogens and Global Health. 2022 Oct 3;116(7):398–409. doi:10.1080/20477724.2022.2038053

European Medicines Agency [Internet]. [cited 2026 Apr 22]. Enflonsia European Medicines Agency. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/enflonsia

Rapid scientific advice on protecting infants against respiratory syncytial virus disease for the European 2025/26 winter season [Internet]. European Centre for Disease Prevention and Control (ECDC); 2025 Nov [cited 2026 Mar 20]. p. 18. Available from: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.ecdc.europa.eu/sites/default/files/documents/RSA-winter-season.pdf?utm_source=chatgpt.com

WHO surveillance case definitions for ILI and SARI [Internet]. [cited 2025 Dec 22]. Available from: https://www.who.int/teams/global-influenza-programme/surveillance-and-monitoring/case-definitions-for-ili-and-sari

QIAamp Viral RNA Mini Kit [Internet]. [cited 2026 Apr 22]. Available from: https://www.qiagen.com/us/products/diagnostics-and-clinical-research/sample-processing/qiaamp-viral-rna-kits

MagCore® Viral Nucleic Acid Extraction Kit High Sensitivity [Internet]. [cited 2026 Apr 22]. Available from: https://www.rbcbioscience.com/product-detail39.htm

RevoDx Viral Pathogens Idil Biotech [Internet]. Available from: https://www.idilbiotech.com/viral-pathogens/.

Fast Track Diagnostics FTD Respiratory pathogens 33 Kit [Internet]. Available from: https://banksiascientific.com.au/wp-content/uploads/2017/10/ftd-2p-3-32_64-validationv1-2016_11-en.pdf?srsltid=AfmBOoqW4vVOmFDIdivd6lrX9Q_WRQuwHcQzx6qUBK1gWAuUF7VQRB_N

Altona RealStar RSV RT-PCR Kit 3.0 [Internet]. Available from: https://altona-diagnostics.com/product/realstarrsv-rt-pcr-kit-3-0/13. Illumina Respiratory Virus Oligos Panel v2 [Internet]. Available from: https://emea.illumina.com/products/bytype/sequencing-kits/library-prep-kits/respiratory-virusoligo-panel.html

Okonechnikov K, Golosova O, Fursov M, the UGENE team. Unipro UGENE: a unified bioinformatics toolkit. Bioinformatics. 2012 Apr 15;28(8):1166–7. doi:10.1093/bioinformatics/bts091

Borges V, Pinheiro M, Pechirra P, Guiomar R, Gomes JP. INSaFLU: an automated open web-based bioinformatics suite “from-reads” for influenza whole-genome-sequencing-based surveillance. Genome Med. 2018 Dec;10(1):46. doi:10.1186/s13073-018-0555-0

Katoh K, Standley DM. MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability. Molecular Biology and Evolution. 2013 Apr 1;30(4):772–80. doi:10.1093/molbev/mst010

Aksamentov I, Roemer C, Hodcroft E, Neher R. Nextclade: clade assignment, mutation calling and quality control for viral genomes. JOSS. 2021 Nov 30;6(67):3773. doi:10.21105/joss.03773

Price MN, Dehal PS, Arkin AP. FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments. Poon AFY, editor. PLoS ONE. 2010 Mar 10;5(3):e9490. doi:10.1371/journal.pone.0009490

Letunic I, Bork P. Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Research. 2024 Jul 5;52(W1):W78–82. doi:10.1093/nar/gkae268

Laham FR, Mansbach JM, Piedra PA, Hasegawa K, Sullivan AF, Espinola JA, et al. Clinical Profiles of Respiratory Syncytial Virus Subtypes A AND B Among Children Hospitalized with Bronchiolitis. Pediatric Infectious Disease Journal. 2017 Aug;36(8):808–10. doi:10.1097/INF.0000000000001596

Midulla F, Nenna R, Scagnolari C, Petrarca L, Frassanito A, Viscido A, et al. How Respiratory Syncytial Virus Genotypes Influence the Clinical Course in Infants Hospitalized for Bronchiolitis. The Journal of Infectious Diseases. 2019 Jan 29;219(4):526–34. doi:10.1093/infdis/jiy496

Saravanos GL, Ramos I, Britton PN, Wood NJ. Respiratory syncytial virus subtype circulation and associated disease severity at an Australian paediatric referral hospital, 2014–2018. J Paediatrics Child Health. 2021 Aug;57(8):1190–5. doi:10.1111/jpc.15419

Espinosa Y, San Martín C, Torres A, Farfán M, Torres J, Avadhanula V, et al. Genomic Loads and Genotypes of Respiratory Syncytial Virus: Viral Factors during Lower Respiratory Tract Infection in Chilean Hospitalized Infants. IJMS. 2017 Mar 21;18(3):654. doi:10.3390/ijms18030654

Hotard AL, Laikhter E, Brooks K, Hartert TV, Moore ML. Functional Analysis of the 60-Nucleotide Duplication in the Respiratory Syncytial Virus Buenos Aires Strain Attachment Glycoprotein. Lyles DS, editor. J Virol. 2015 Aug 15;89(16):8258–66. doi:10.1128/JVI.01045-15

Wilkins D, Langedijk AC, Lebbink RJ, Morehouse C, Abram ME, Ahani B, et al. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data. The Lancet Infectious Diseases. 2023 Jul;